SCHEMBL2615154

SCHEMBL2615154

Cc1ccc(C(=O)n2c(C)c(CC(=O)O)c3cc([18F])ccc32)cc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 10/20 0.83
AKR1C2 P52895 10/20 0.83
PTGS1 P23219 3/20 0.63
PTGS2 P35354 3/20 0.63
PTGDR2 Q9Y5Y4 2/20 0.61
LMNA P02545 2/20 0.60
CYP1A2 P05177 2/20 0.60
CYP2D6 P10635 2/20 0.60
CYP2C9 P11712 2/20 0.60
HIF1A Q16665 2/20 0.60
NPSR1 Q6W5P4 2/20 0.60
TSHR P16473 1/20 0.60
NFKB1 P19838 1/20 0.60
AKR1C4 P17516 2/20 0.59
AKR1C1 Q04828 2/20 0.59
ABCB1 P08183 2/20 0.59
KDM4E B2RXH2 1/20 0.59
MEN1 O00255 1/20 0.59
PTGES O14684 1/20 0.59
ABCC3 O15438 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2615155 1.00 AKR1C3 (0.83) AKR1C3AKR1C2PTGS1PTGS2PTGDR2
SCHEMBL13285191 0.95 AKR1C3 (0.86) AKR1C3AKR1C2PTGS1PTGS2PTGDR2
SCHEMBL2615153 0.91 AKR1C3 (1.00) AKR1C3AKR1C2PTGS1PTGS2PTGDR2
SCHEMBL2615156 0.91 AKR1C3 (1.00) AKR1C3AKR1C2PTGS1PTGS2PTGDR2
SCHEMBL17946351 0.90 AKR1C3 (0.78) AKR1C3AKR1C2PTGS1PTGS2PTGDR2
SCHEMBL2997297 0.87 PTGS2 (0.79) AKR1C3AKR1C2PTGS1PTGS2PTGDR2
SCHEMBL13802249 0.87 AKR1C3 (0.74) AKR1C3AKR1C2PTGS1PTGS2PTGDR2
SCHEMBL4055730 0.86 PTGS1 (0.82) AKR1C3AKR1C2PTGS1PTGS2PTGDR2
SCHEMBL16557623 0.85 AKR1C3 (0.71) AKR1C3AKR1C2PTGS1PTGS2PTGDR2
SCHEMBL5796934 0.84 AKR1C3 (1.00) AKR1C3AKR1C2PTGS1PTGS2PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120095217-A1 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095217-A1 FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF FLI1, CDC73, FOS AKR1C3 3710/4885AKR1C2 3372/4885PTGS1 4850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.